Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Opportunities and considerations for visualising neuroimaging data on very large displays.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
GRAPE: a graphical pipeline environment for image analysis in adaptive magnetic resonance imaging.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space.
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.
Capacity for financial decision making in multiple sclerosis.
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-NO.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-YES.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
Association between seasonal factors and multiple sclerosis.
Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce.
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

Pages